Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) was upgraded by equities researchers at BidaskClub from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday.

Several other research analysts also recently weighed in on the company. Canaccord Genuity reaffirmed a “hold” rating and set a $26.00 target price on shares of Sabra Healthcare REIT in a research note on Tuesday, May 9th. Zacks Investment Research raised Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $32.00 target price for the company in a research note on Wednesday, April 12th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $30.00 target price on shares of Sabra Healthcare REIT in a research note on Monday, May 8th. Jefferies Group LLC reaffirmed a “hold” rating and set a $28.00 target price on shares of Sabra Healthcare REIT in a research note on Friday, May 12th. Finally, Mizuho reaffirmed a “neutral” rating and set a $28.00 target price (up from $22.00) on shares of Sabra Healthcare REIT in a research note on Monday, February 27th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company. Sabra Healthcare REIT presently has an average rating of “Hold” and an average price target of $27.71.

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Sabra Healthcare REIT (NASDAQ SBRA) traded up 0.96% during midday trading on Tuesday, reaching $24.18. 2,368,466 shares of the company’s stock were exchanged. The firm has a market capitalization of $1.58 billion, a price-to-earnings ratio of 16.71 and a beta of 1.00. The firm’s 50 day moving average is $24.15 and its 200 day moving average is $25.59. Sabra Healthcare REIT has a 52 week low of $19.30 and a 52 week high of $29.10.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings data on Monday, May 8th. The real estate investment trust reported $0.25 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by $0.33. Sabra Healthcare REIT had a return on equity of 10.35% and a net margin of 40.22%. The company had revenue of $62.65 million during the quarter, compared to analysts’ expectations of $63.47 million. During the same quarter in the prior year, the company posted $0.54 EPS. The company’s revenue for the quarter was up .1% on a year-over-year basis. On average, equities analysts anticipate that Sabra Healthcare REIT will post $1.20 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 31st. Stockholders of record on Thursday, May 18th were issued a dividend of $0.43 per share. The ex-dividend date of this dividend was Tuesday, May 16th. This is a boost from Sabra Healthcare REIT’s previous quarterly dividend of $0.42. This represents a $1.72 dividend on an annualized basis and a dividend yield of 7.11%. Sabra Healthcare REIT’s dividend payout ratio is currently 119.45%.

TRADEMARK VIOLATION NOTICE: This news story was published by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this news story can be read at https://www.americanbankingnews.com/2017/06/20/sabra-healthcare-reit-inc-sbra-rating-increased-to-hold-at-bidaskclub.html.

Several institutional investors have recently added to or reduced their stakes in SBRA. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Sabra Healthcare REIT by 14.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,799 shares of the real estate investment trust’s stock worth $106,000 after buying an additional 471 shares in the last quarter. Bank of Montreal Can boosted its position in shares of Sabra Healthcare REIT by 44.1% in the first quarter. Bank of Montreal Can now owns 3,893 shares of the real estate investment trust’s stock worth $109,000 after buying an additional 1,191 shares during the period. Russell Investments Group Ltd. purchased a new position in shares of Sabra Healthcare REIT during the fourth quarter worth approximately $120,000. Ameritas Investment Partners Inc. purchased a new position in shares of Sabra Healthcare REIT during the first quarter worth approximately $156,000. Finally, Stratos Wealth Partners LTD. purchased a new position in shares of Sabra Healthcare REIT during the first quarter worth approximately $207,000. Institutional investors and hedge funds own 99.47% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.